Twitter Beğeni Hilesi

🗓️Yesterday at #ESMOImmuno23! Discover our poster 'IMMUcan – Toward a better understanding of the tumour microenvironment to inform precision oncology approaches' Our goal is to get a deeper understanding of the impact of current treatments! Innovative Health Initiative EORTC

🎉Wrapping up an inspiring #ESMOImmuno23! Our team successfully presented the latest IMMUcan research, fostering valuable collaborations with fellow researchers. Tune in to our IMMUcan channels in the next few days for more insight on the conference!

🔍 Reflecting on #ESMOImmuno23! 🗓️Last week, our IMMUcan team showcased seven poster presentations, unveiling the insights gained from IMMUcan so far. Missed the congress? No worries! Stay tuned for insights and impressions in the coming weeks.

We love working together with our #partners within IMMUcan! Today, we highlight our collaboration with Cliniques universitaires Saint-Luc. Why is this partnership important? Dr. Philippe Stevens, PhD candidate, explains. Curious to learn more about the project? Go to immucan.eu

It’s been two months since we joined #ESMOIO2023! We proudly presented the latest IMMUcan #cancerresearch. But what exactly did we bring to the table during those days in early December 2023? Let’s look back! This week, we highlight Daniel Schulz and team!

What is the story behind IMMUcan? We are happy to explain! 📽 Watch the video to understand more about the ins and outs of the rationale behind IMMUcan. How to join the project? Go to immucan.eu to learn all about it!

💬 "Why do some #patients respond to cancer treatments, while others don't?" IMMUcan studies the #TME to gain a deeper understanding of how the immune system and cancer cells interact at the molecular and cellular level. ➡ Go to immucan.eu to learn more!

That’s a wrap for the IMMUcan general assembly! Over the past two days we went through updates from partners & explored future plans. More insights from the research done in the project will follow!

Huge news! Study by Amelie Franken & team featured on the cover of Immunity by Cell Press! The research reveals key #immune mechanisms in #HNSCC patients. Read more: bit.ly/44KmgnC

We welcome Novigenix to our consortium! Powered by #AI and next-generation #RNA sequencing, the Novigenix’ LITOseek platform will enhance the immune profiling capabilities of IMMUcan. We aim to bridge the gap between research and clinical application. bit.ly/3wVwghj

Did you know that over 1800 patients’ #data has been analysed by the IMMUcan teams? Our research aims to enhance cancer #immunology understanding and improve #immunotherapy treatments. Clinicians, researchers, sponsors, and patients can learn more here: immucan.eu/how-to-collabo…

The future of #cancer care is personalised! IMMUcan uses detailed molecular and cellular profiling to understand why some #patients respond to treatments while others don't. Learn more: bit.ly/3XjBK0d

We are thrilled to announce that we have reached 2000 #patients enrolled, making IMMUcan the largest #immuno-profiling effort in Europe! This is a huge step forward in advancing #cancer care: immucan.eu

IMMUcan seeks to identify #biomarkers and mechanisms that can inform better, personalised treatment strategies for #cancer patients. Learn more about the work we do: immucan.eu

Exciting September for IMMUcan! Our research will be featured at 4 prestigious events, with Dr Ewa Szczurek and her team presenting the cutting-edge models FACTM, Cellohood, and Spacelet, advancing multi-modal data integration & spatial biology.